Media & News
Endocrine Pathway Trailblazer: Q&A with Katrin Svensson, PhD
By Glenda Fauntleroy Shaw, Endocrine News
GLP-1s & Novel Peptides in Obesity, Diabetes & Metabolic Health
Nick Jikomes, PhD speaks with Dr. Katrin Svensson on the Mind & Matter Podcast: Science, Health, Metabolism | Episode 298.
ENDO 2026
Jameel Lone gave a Rising Stars power talk, A BRINP3-Derived Peptide Drives Non-Aversive Appetite Suppression via PVH Circuits, at ENDO 2026 on June 13-15, 2026.
Katrin Svensson received the Endocrine Society Richard E. Weitzman Outstanding Early Career Investigator Award.
ADA 2026
Laetitia Voilquin-Coassolo gave a talk, Harnessing Prohormone Cleavage Prediction to Discover Antiobesity Peptides, at the American Diabetes Association’s 2026 Scientific Sessions on June 5, 2026.
Bay Area Aging Meeting at the Buck Institute
Jameel Lone had a talk at the 26th Bay Area Aging Meeting at Buck on May 15, 2026.
Wu Tsai Performance Undergraduate Research Award for 2026
Congratulations to our undergraduate researcher, Michelle To, on receiving the Wu Tsai Performance Undergraduate Research Award for 2026!
Wu Tsai Human Performance Alliance | Undergraduate Research Program
Our lab’s focus
American Diabetes Association (ADA) covered our lab’s work at the American Diabetes Association® 85th Scientific Sessions in Chicago on June 20–23, 2025.
Here, we talk about our work on peptide hormones and the approaches we are taking to better understand metabolic regulation.
Featuring Svensson Lab and our collaborators.
Trendstalk
Harnessing the power of peptides: advances and collaborations in biochemistry
Cell Metabolism 20th anniversary Voices: Part 2 of 3
Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects
By Krista Conger Stanford medicine
A Stanford Medicine study taps artificial intelligence to find a naturally occurring molecule called a peptide that suppressed appetite and led to weight loss in mice and pigs.